Privat · Företag · Aksjeselskap
Immunoquest Therapeutics AS
931 892 266 ↗Research and experimental development on natural sciences and engineering · NACE 72.100Oslo
↳ Brreg · companies
Aktivitetsenaste 24 mĂĄn
Ingen platsannonsaktivitet registrerad
totaler registrerade · annonser-över-tid-serie ännu inte i Intelligo
Registerändringar
Inga registrerade ändringar.
NAV + JobStream · company_hiring · Brreg · company_changes
Tidslinjealla källor
Audit opinionThe company has resolved not to have the annual accounts audited, so no auditor's report is included. — Selskapet har besluttet at arsreg...Årsredovisning · 2025-12-31
Going concernThe notes include a note on uncertainty about going concern, stating that the board has initiated measures to improve equity and liquidit...Årsredovisning · 2025-12-31
OwnershipShareholders are Inven2 AS with 60 % (18 000 shares) and The N AS and Jon Amund Kyte with 20 % (6 000 shares) each. — INVEN2 AS The N AS...Årsredovisning · 2025-12-31
Share capitalShare capital is NOK 30 000 (30 000 ordinary shares of NOK 1), and an unregistered capital increase of NOK 1 856 693 is recorded in paid-...Årsredovisning · 2025-12-31
Related partyShareholder Inven2 AS has provided a loan to the company with an outstanding balance of NOK 1 877 446. — En av selskapets aksjonaerer, In...Årsredovisning · 2025-12-31
Loan or financingInterest of NOK 93 508 was charged on the shareholder loan during the year and the loan is unsecured. — regnskapsaret med 93.508. Lanet e...Årsredovisning · 2025-12-31
Staff numbersThe company employed 1 full-time equivalent during the financial year. — Antall arsverk sysselsatt i regnskapsaret: 1Årsredovisning · 2025-12-31
RemunerationTotal payroll cost was NOK 1 235 533 in 2025 (salary 1 034 721, employer's tax 152 589, other benefits 48 223) against NOK 604 477 in 202...Årsredovisning · 2025-12-31
Deferred taxDeferred tax/deferred tax asset is computed on temporary differences; the tax-reducing differences including the loss carryforward of 3 1...Årsredovisning · 2025-12-31
OtherThe company conducts medical research and operates from Oslo, and accounting principles were unchanged from 2024 to 2025. — Selskapet dri...Årsredovisning · 2025-12-31
THE N AS acquired 20.0 pctNy ägare · 2024-12-31
Skiwo · company_events
Jobbannonser pĂĄ NAV Arbeidsplassen12 MĂ…N
Inga jobbannons registrerade de senaste 12 mĂĄnaderna.
NAV Arbeidsplassen · company_job_ad_months
PlatsOslo
Oslo
endast kommun · gatuadress + koordinater ännu inte i Intelligo
Brreg · registrerad kommun